Sitravatinib malate
Product Specifications
CAS Number
2244864-88-6
Target
VEGFR, FLT, Discoidin Domain Receptor (DDR), c-Kit, Trk receptor, TAM Receptor
Related Pathways
Angiogenesis, Tyrosine Kinase/Adaptors
Bioactivity
Sitravatinib malate is an orally bioavailable receptor inhibitor of tyrosine kinase (RTK) (IC50s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5 nM, and 9 nM for Axl, MER, VEGFR3, VEGFR2, VEGFR1, KIT, FLT3, DDR2, DDR1, TRKA, TRKB, respectively.), shows potent single-agent antitumor efficacy and enhances the activity of PD-1 blockade through promoting an antitumor immune microenvironment.
Smiles
[C@H](CC(O)=O)(C(O)=O)O.C(NC1=CC(F)=C(OC2=C3C(C=C(S3)C4=CC=C(CNCCOC)C=N4)=NC=C2)C=C1)(=O)C5(C(NC6=CC=C(F)C=C6)=O)CC5
Molecular Formula
C37H35F2N5O9S
Molecular Weight
763.76
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
040668-ML650 100 µL
PTPRCAP, ID (PTPRCAP, LPAP, Protein tyrosine phosphatase receptor type C-associated protein, CD45-associated protein, Lymphocyte phosphatase-associated phosphoprotein) (MaxLight 650) discontinued
Sign In for Pricing
View Details 
